<?xml version="1.0" encoding="UTF-8"?>
<p>The limitations of antifungal therapy, such as high cost, toxicity, drug interactions, and low drug bioavailability, are factors that contribute to the inefficiency of conventional antifungals, as represented by azole, polyenic, and echinocandin compounds.
 <xref rid="cit0005" ref-type="bibr">5</xref> In addition, the emergence of drug-resistant strains has stimulated the search for new antifungal agents with different mechanisms of action.
 <xref rid="cit0006" ref-type="bibr">6</xref>
</p>
